Home/Filings/4/0001209191-12-015002
4//SEC Filing

BIOMIMETIC THERAPEUTICS, INC. 4

Accession 0001209191-12-015002

CIK 0001138400operating

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 3:20 PM ET

Size

10.0 KB

Accession

0001209191-12-015002

Insider Transaction Report

Form 4
Period: 2012-02-29
BULLOCK LAWRENCE E
Chief Financial Officer
Transactions
  • Award

    Stock Options (right to buy)

    2012-02-29+80,00080,000 total
    Exercise: $2.08From: 2013-02-28Exp: 2022-02-28Common Stock (80,000 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    28,000
  • Common Stock

    58,723
Footnotes (2)
  • [F1]Mr. Bullock disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.
  • [F2]Stock options vest 25% each year on the anniversary of the 2/29/2012 grant date.

Issuer

BIOMIMETIC THERAPEUTICS, INC.

CIK 0001138400

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001138400

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 3:20 PM ET
Size
10.0 KB